DarioHealth (DRIO) Liabilities and Shareholders Equity (2012 - 2026)

DarioHealth's Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $103.3 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 10.66% year-over-year to $103.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $439.4 million (down 5.82% YoY) and the FY2025 annual result came in at $110.1 million, down 7.41% from the prior year.
• Liabilities and Shareholders Equity was $103.3 million for Q1 2026 at DarioHealth, down from $110.1 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $137.3 million in Q2 2022 and bottomed at $96.4 million in Q4 2023.
• A 5-year average of $116.5 million and a median of $117.2 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity slipped 19.13% — and 2024, when it increased 26.81%.
• DarioHealth's Liabilities and Shareholders Equity stood at $119.2 million in 2022, then fell by 19.13% to $96.4 million in 2023, then grew by 23.34% to $118.9 million in 2024, then dropped by 7.41% to $110.1 million in 2025, then fell by 6.17% to $103.3 million in 2026.
• Business Quant data shows DRIO's Liabilities and Shareholders Equity at $103.3 million in Q1 2026, $110.1 million in Q4 2025, and $117.7 million in Q3 2025.